SEC Tracker
Get the app
CLPT · XBRL financial data

ClearPoint Neuro financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (CLPT's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue6,810*7,6397,8588,1227,771*8,4859,2158,86110,410*12,12810,88012,075
Revenue from contracts with customers6,810*7,6397,8588,1227,771*8,4859,2158,86110,410*12,12810,88012,075
Cost of revenue2,797*3,1142,8703,2753,009*3,3533,6593,2614,006*4,3724,1705,016
Gross profit4,013*4,5254,9884,8474,762*5,1325,5565,6006,404*7,7566,7107,059
Research and development2,652*2,6253,1203,3153,332*3,3793,8293,4523,237*4,5224,6324,018
Selling, general and administrative2,720*2,8412,7733,1553,229*4,0823,3883,5865,442*4,9975,5543,841
Operating income (loss)(4,706)*(4,231)(4,739)(5,172)(5,604)*(6,163)(5,680)(5,276)(7,045)*(8,478)(10,244)(6,332)
Interest income————year only151285396381*351289292
Interest expense————year only03659391,084*1,3821,4131,446
Other income (expense)(4)*(26)5(11)(8)*4(52)(64)(34)*(35)(7)22
Income tax expense (benefit)year only151514(32)*182584*8(38)(4)
Net income (loss)(4,619)*(4,146)(4,408)(4,974)(5,386)*(6,026)(5,837)(5,891)(7,786)*(9,552)(11,337)(7,460)
Earnings per share, basic USD per share(0.19)*(0.16)(0.16)(0.18)(0.20)*(0.22)(0.21)(0.21)(0.27)*(0.32)(0.38)(0.24)
Earnings per share, diluted USD per share(0.19)*(0.16)(0.16)(0.18)(0.20)*(0.22)(0.21)(0.21)(0.27)*(0.32)(0.38)(0.24)
Weighted average shares, basic thousands of shares24,623*25,45227,46827,59227,586*27,71928,25828,42828,843*29,54730,16730,983
Weighted average shares, diluted thousands of shares24,623*25,45227,46827,59227,586*27,71928,25828,42828,843*29,54730,16730,983

Balance sheet

CSV

Fiscal quarters (CLPT's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents23,14035,35332,84521,57320,10412,38741,54138,22145,92335,59329,36346,184
Short-term investments0———————————
Accounts receivable3,2112,5113,4753,8754,7133,6514,2604,0006,5498,6628,3958,017
Inventory7,9117,9608,0317,0596,8636,5826,2936,5838,3598,5738,8139,772
Prepaid and other current assets1,9101,7462,2051,8231,6831,5941,8972,5252,7692,0492,3612,741
Total current assets36,17247,57046,55634,33033,36324,21453,99151,32963,60054,87748,93266,714
Property and equipment, net1,3891,3471,5451,6952,0052,1832,0192,1142,6212,9142,9863,122
Right-of-use asset3,5643,4473,3303,2103,0862,9606,1395,9558,43013,08812,64421,195
Goodwill————7,472———7,4727,4727,4727,472
Total assets42,66153,63752,57440,19339,18930,07062,86960,35797,74793,41686,741112,728
Accounts payable3938448229551,3401,2161,5317231,2562,3302,1531,060
Total current liabilities7,43015,15716,6947,55410,3536,8667,3988,05310,7659,48010,3139,869
Lease liability, non-current3,5683,4383,3023,1583,0112,8606,2806,1958,46113,71013,52022,661
Total liabilities21,48819,05320,44211,19213,80010,08343,12644,48369,72774,57575,96585,461
Accumulated deficit(172,456)(176,602)(181,010)(185,984)(191,370)(197,396)(203,233)(209,124)(216,910)(226,462)(237,799)(245,259)
Total stockholders' equity21,17334,58432,13229,00125,38919,98719,74315,87428,02018,84110,77627,267
Total liabilities and equity42,66153,63752,57440,19339,18930,07062,86960,35797,74793,41686,741112,728
Common shares outstanding (cover page) thousands of shares26,97627,42027,59627,58527,63227,98928,42728,42329,66429,99030,50432,054

Cash flows

CSV

Fiscal quarters (CLPT's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(4,619)*(4,146)(4,408)(4,974)(5,386)*(6,026)(5,837)(5,891)(7,786)*(9,552)(11,337)(7,460)
Stock-based compensation1,543*1,5041,796*1,904*1,703*1,9082,269*2,022*1,981*2,2182,271*1,880*
Depreciation and amortization183*243233*264*240*103396*66*249*86150*103*
Net cash from operating activities(1,169)*(3,840)(2,668)*(1,199)*(1,243)*(6,172)(2,552)*(3,121)*(12,080)*(7,967)(7,015)*(20,100)
Purchases of property and equipment21*00*12*263*18391*199*49*645214*137*
Net cash from investing activities(188)*00*(12)*(263)*(183)(91)*(199)*1,088*(645)(214)*(137)*
Proceeds from issuing common stock0*16,1830*0*(34)*03,263*0*0*——0*
Net cash from financing activities155*16,053160*(10,061)*37*(1,362)31,977*0*19,564*(1,845)1,001*22,071*
Net change in cash(1,202)*12,213(2,508)*(11,272)*(1,469)*(7,717)29,334*(3,320)*8,572*(10,457)(6,228)*16,822*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
ClearPoint Neuro46,18412,075(20,100)32.1M6.6 quarters 10-QSep 30, 2026
Outset Medical35,00531,635(9,635)*18.8M15.3 quarters 10-QJun 30, 2026
EBR Systems59,3502,637(17,194)*75.3M5.0 quarters 10-QJun 30, 2026
NeuroPace12,53822,826(3,903)*34.3M13.2 quarters 10-QJun 30, 2026
Orthopediatrics17,14172,6614,506*26.1M— 10-QSep 30, 2026
Mobia Medical177,09013,505(15,670)*33.3M11.3 quarters 10-QJun 30, 2026
Venus Concept4,31213,776(4,890)*1.9M0.9 quarters 10-QSep 30, 2025
Butterfly Network122,30132,598(2,266)*not reported10.3 quarters 10-QSep 30, 2026
Pulse Biosciences101,620434(18,709)*71.3M5.4 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.